Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents

Ultrasound in Medicine and Biology

Volumn 40, Issue 2, 2014, Pages 410-421

  Raymond, Jason L ^a   Haworth, Kevin J ^a,b   Bader, Kenneth B ^b   Radhakrishnan, Kirthi ^a   Griffin, Joseph K ^a   Huang, Shao Ling ^c   McPherson, David D ^c   Holland, Christy K ^a,b  

^a 705 Engineering Research Center   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Broadband characterization; Definity; Echogenic liposomes; Microbubbles; MicroMarker; Polyvinylidene fluoride transducer; Size distribution; Ultrasound contrast agents

Indexed keywords

BROADBAND CHARACTERIZATION; DEFINITY; ECHOGENIC LIPOSOMES; MICROBUBBLES; MICROMARKER; POLYVINYLIDENE FLUORIDE TRANSDUCERS; ULTRASOUND CONTRAST AGENT;

BLOOD; LIPOSOMES; MAMMALS; PHOSPHOLIPIDS; PHYSIOLOGY; SIZE DISTRIBUTION; TRANSDUCERS;

BUBBLES (IN FLUIDS);

BOVINE SERUM ALBUMIN; ECHO CONTRAST MEDIUM; ECHOGENIC LIPOSOME; MICROMARKER; PERFLUTREN; PHOSPHOLIPID; UNCLASSIFIED DRUG; VEVO MICROMARKER;

ACOUSTICS; ARTICLE; BLOOD; BODY TEMPERATURE; BROADBAND ATTENUATION; FREQUENCY ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; ROOM TEMPERATURE; SIGNAL PROCESSING; SOUND RELATED PHENOMENA; TEMPERATURE SENSITIVITY;

BROADBAND CHARACTERIZATION; DEFINITY; ECHOGENIC LIPOSOMES; MICROBUBBLES; MICROMARKER; POLYVINYLIDENE FLUORIDE TRANSDUCER; SIZE DISTRIBUTION; ULTRASOUND CONTRAST AGENTS;

COATED MATERIALS, BIOCOMPATIBLE; CONTRAST MEDIA; FLUOROCARBONS; PHANTOMS, IMAGING; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 84891632612     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2013.09.018     Document Type: Article

References (51)

1. Alkan-Onyuksel H., Demos S.M., Lanza G.M., Vonesh M.J., Klegerman M.E., Kane B.J., Kuszak J., Mcpherson D.D. Development of inherently echogenic liposomes as an ultrasonic contrast agent. JPharm Sci 1996, 85:486-490.
2. Altman P.L. Handbook of respiration 1958, Saunders, Philadelphia.
3. Methods for specifying acoustic properties of tissue mimicking phantoms and objects 1995, AIUM Technical Standards Committee, Laurel, MD: American Institute of Ultrasound in Medicine (AIUM).
4. Bekeredjian R., Grayburn P.A., Shohet R.V. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. JAm Coll Cardiol 2005, 45:329-335.
5. Buchanan K.D., Huang S., Kim H., MacDonald R.C., McPherson D.D. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. JPharm Sci 2008, 97:2242-2249.
6. Chatterjee D., Sarkar K., Jain P., Schreppler N.E. On the suitability of broadband attenuation measurement for characterizing contrast microbubbles. Ultrasound Med Biol 2005, 31:781-786.
7. Chen J., Zhu Z. Ultrasound attenuation in encapsulated microbubble suspensions: The multiple scattering effects. Ultrasound Med Biol 2006, 32:961-969.
8. de Jong N., Hoff L. Ultrasound scattering properties of Albunex microspheres. Ultrasonics 1993, 31:175-181.
9. de Jong N., Hoff L., Skotland T., Bom N. Absorption and scatter of encapsulated gas filled microspheres: Theoretical considerations and some measurements. Ultrasonics 1992, 30:95-103.
10. Demos S.M., Alkan-Onyuksel H., Kane B.J., Ramani K., Nagaraj A., Greene R., Klegerman M., McPherson D.D. Invivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. JAm Coll Cardiol 1999, 33:867-875.
11. Elbayoumi T.A., Torchilin V.P. Liposomes for targeted delivery of antithrombotic drugs. Expert Opin Drug Deliv 2008, 5:1185-1198.
12. Faez T., Goertz D., de Jong N. Characterization of Definity™ ultrasound contrast agent at frequency range of 5-15 MHz. Ultrasound Med Biol 2011, 37:338-342.
13. Feinstein S.B. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. JAm Coll Cardiol 2006, 48:236-243.
14. Goertz D.E., de Jong N., van der Steen A.F. Attenuation and size distribution measurements of Definity and manipulated Definity populations. Ultrasound Med Biol 2007, 33:1376-1388.
15. Gorce J.M., Arditi M., Schneider M. Influence of bubble size distribution on the echogenicity of ultrasound contrast agents: A study of SonoVue. Invest Radiol 2000, 35:661-671.
16. TM. Ultrasound Med Biol 2012, 38:1298-1305.
17. Hitchcock K.E., Caudell D.N., Sutton J.T., Klegerman M.E., Vela D., Pyne-Geithman G.J., Abruzzo T., Cyr P.E., Geng Y.J., McPherson D.D., Holland C.K. Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel exvivo mouse aorta model. JControl Release 2010, 144:288-295.
18. Hoff L. Acoustic characterization of contrast agents for medical ultrasound imaging 2001, Springer, Berlin/Heidelberg.
19. Hoff L., Sontum P.C., Hovem J.M. Oscillations of polymeric microbubbles: Effect of the encapsulating shell. JAcoust Soc Am 2000, 107:2272-2280.
20. Huang S. Ultrasound-responsive liposomes. Liposomes: Methods and protocols 2010, Humana Press, New York. V. Weissig (Ed.).
21. Huang S.L. Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1167-1176.
22. Huang S.L., Hamilton A.J., Nagaraj A., Tiukinhoy S.D., Klegerman M.E., Mcpherson D.D., Macdonald R.C. Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. JPharm Sci 2001, 90:1917-1926.
23. Huang S.L., Hamilton A.J., Pozharski E., Nagaraj A., Klegerman M.E., McPherson D.D., MacDonald R.C. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol 2002, 28:339-348.
24. Huang S.L., MacDonald R.C. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta Biomembr 2004, 1665:134-141.
25. Klegerman M.E., Wassler M., Huang S.L., Zou Y., Kim H., Shelat H.S., Holland C.K., Geng Y.J., McPherson D.D. Liposomal modular complexes for simultaneous targeted delivery of bioactive gases and therapeutics. JControl Release 2010, 142:326-331.
26. Klibanov A.L. Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol 2006, 41:354-362.
27. Kopechek J.A., Haworth K.J., Radhakrishnan K., Huang S.L., Klegerman M.E., McPherson D.D., Holland C.K. The impact of bubbles on measurement of drug release from echogenic liposomes. Ultrason Sonochem 2013, 20:1121-1130.
28. Kopechek J.A., Haworth K.J., Raymond J.L., Douglas Mast T., Perrin S.R., Klegerman M.E., Huang S., Porter T.M., McPherson D.D., Holland C.K. Acoustic characterization of echogenic liposomes: Frequency-dependent attenuation and backscatter. JAcoust Soc Am 2011, 130:3472-3481.
29. Kornmann L.M., Reesink K.D., Reneman R.S., Hoeks A.P.G. Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries. Ultrasound Med Biol 2010, 36:181-191.
30. Kwan J.J., Borden M.A. Microbubble dissolution in a multigas environment. Langmuir 2010, 26:6542-6548.
31. Laing S.T., McPherson D.D. Cardiovascular therapeutic uses of targeted ultrasound contrast agents. Cardiovasc Res 2009, 83:626-635.
32. Lindner J.R. Molecular imaging with contrast ultrasound and targeted microbubbles. JNucl Cardiol 2004, 11:215-221.
33. Marmottant P., van der Meer S., Emmer M., Versluis M., de Jong N., Hilgenfeldt S., Lohse D. Amodel for large amplitude oscillations of coated bubbles accounting for buckling and rupture. JAcoust Soc Am 2005, 118:3499-3505.
34. Marsh J.N., Hall C.S., Hughes M.S., Mobley J., Miller J.G., Brandenburger G.H. Broadband through-transmission signal loss measurements of Albunex® suspensions at concentrations approaching invivo doses. JAcoust Soc Am 1997, 101:1155-1161.
35. Mulvana H., Stride E., Hajnal J.V., Eckersley R.J. Temperature dependent behavior of ultrasound contrast agents. Ultrasound Med Biol 2010, 36:925-934.
36. Patil H., Main M.L. The history of product label changes for DEFINITY® in the US. US Cardiol 2012, 9:35-39.
37. Paul S., Russakow D., Nahire R., Nandy T., Ambre A.H., Katti K., Mallik S., Sarkar K. Invitro measurement of attenuation and nonlinear scattering from echogenic liposomes. Ultrasonics 2012, 52:962-969.
38. Qin S., Caskey C.F., Ferrara K.W. Ultrasound contrast microbubbles in imaging and therapy: Physical principles and engineering. Phys Med Biol 2009, 54:R27-R57.
39. Radhakrishnan K., Haworth K.J., Huang S.-, Klegerman M.E., McPherson D.D., Holland C.K. Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom. Ultrasound Med Biol 2012, 38:1970-1981.
40. Sarkar K., Katiyar A., Jain P. Growth and dissolution of an encapsulated contrast microbubble: effects of encapsulation permeability. Ultrasound Med Biol 2009, 35:1385-1396.
41. Sarkar K., Shi W.T., Chatterjee D., Forsberg F. Characterization of ultrasound contrast microbubbles using invitro experiments and viscous and viscoelastic interface models for encapsulation. JAcoust Soc Am 2005, 118:539-550.
42. Smith D.A., Vaidya S.S., Kopechek J.A., Huang S.L., Klegerman M.E., McPherson D.D., Holland C.K. Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol 2010, 36:145-157.
43. Stapleton S., Goodman H., Zhou Y., Cherin E., Henkelman R.M., Burns P.N., Foster F.S. Acoustic and kinetic behaviour of Definity in mice exposed to high frequency ultrasound. Ultrasound Med Biol 2009, 35:296-307.
44. Stride E. Physical principles of microbubbles for ultrasound imaging and therapy. Cerebrovasc Dis 2009, 27(Suppl 2):1-13.
45. Stride E., Saffari N. Investigating the significance of multiple scattering in ultrasound contrast agent particle populations. IEEE Trans Ultrason Ferroelectr Freq Control 2005, 52:2332-2345.
46. Sutton J.T., Haworth K.J., Pyne-Geithman G., Holland C.K. Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv 2013, 10:573-592.
47. Tiukinhoy-Laing S.D., Huang S., Klegerman M., Holland C.K., McPherson D.D. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 2007, 119:777-784.
48. VisualSonics PN11691-Vevo MicroMarker™ Non-Targeted Contrast Agent Kit: Protocol and Information Booklet Rev 1.4. Toronto.
49. Vos HJ, Emmer M, de Jong N. Oscillation of single microbubbles at room versus body temperature. In: Proceedings, 2008 IEEE International Ultrasonics Symposium, Beijing, China, November 2-5, 2008. Beijing edition. New York: IEEE, 2008:982-984.
50. Weissig V. Liposomes: Methods and protocols 2010, Humana Press, New York.
51. Whittle P. Prediction and regulation by linear least-square methods 1983, University of Minnesota Press, Minneapolis, MN. 2nd rev. edition.